(Q54246366)

26 May 2018

title

Long-term pulmonary consequences of respiratory distress syndrome in preterm infants treated with exogenous surfactant. (English)

1 reference

26 May 2018

1 reference

Abbasi S

1

1 reference

26 May 2018

Bhutani VK

series ordinal

2

1 reference

26 May 2018

Gerdes JS

series ordinal

3

1 reference

26 May 2018

language of work or name

English

0 references

publication date

1 March 1993

1 reference

26 May 2018

The Journal of Pediatrics

published in

1 reference

26 May 2018

volume

122

1 reference

26 May 2018

issue

3

1 reference

26 May 2018

page(s)

446-452

1 reference

26 May 2018

Prophylactic treatment of very premature infants with human surfactant

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983439-0

Double-blind controlled trial of single-dose treatment with bovine surfactant in severe hyaline membrane disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983439-0

A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983439-0

A controlled trial of human surfactant replacement therapy for severe respiratory distress syndrome in very low birth weight infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983439-0

Effect of exogenous surfactant on total respiratory system compliance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983439-0

Effects of exogenous surfactant therapy on dynamic compliance during mechanical breathing in preterm infants with hyaline membrane disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983439-0

Changes in pulmonary mechanics after the administration of surfactant to infants with respiratory distress syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983439-0

Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983439-0

A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983439-0

Determinants of forced expiratory flows in newborn infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983439-0

Expiratory flow limitation in infants with bronchopulmonary dysplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983439-0

Partial expiratory flow-volume curves in infants and young children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983439-0

A simple method for measuring functional residual capacity by N2 washout in small animals and newborn infants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983439-0

Functional residual capacity in normal neonates and children up to 5 years of age determined by a N2 washout method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983439-0

Evaluation of neonatal pulmonary mechanics and energetics: a two factor least mean square analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983439-0

Chestwall compliance in full-term and premature infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983439-0

Influence of chest wall distortion on esophageal pressure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983439-0

Distortion of chest wall and work of diaphragm in preterm infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983439-0

Noninvasive determination of respiratory mechanics during mechanical ventilation of neonates: a review of current and future techniques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983439-0

Pulmonary mechanics in normal infants and young children during first 5 years of life.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983439-0

Pulmonary mechanics and energetics of normal, non-ventilated low birthweight infants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983439-0

Pulmonary function in the sick newborn infant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983439-0

Serial determination of pulmonary function in infants with chronic lung disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983439-0

Pulmonary mechanics and energetics in preterm infants who had respiratory distress syndrome treated with synthetic surfactant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983439-0

Pulmonary function in infancy and in childhood following mechanical ventilation in the neonatal period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983439-0

Pulmonary function at 1 year of age in survivors of neonatal respiratory distress: a multivariate analysis of factors associated with sequelae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983439-0

Infants with upper respiratory illnesses have significant reductions in maximal expiratory flow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983439-0

Effect of single dose surfactant on pulmonary function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983439-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(05)83439-0

1 reference

26 May 2018

PubMed ID

8441104

1 reference

26 May 2018